参考文献/References:
[1]Udomsinprasert W,Honsawek S,Poovorawan Y.Adiponectin as a novel biomarker for liver fibrosis[J].World J Hepatol,2018,10(10):708-718.[2]Gamberi T,Magherini F,Modesti A,et al.Adiponectin Signaling Pathways in Liver Diseases[J].Biomedicines,2018,6(2):52.[3]Park PH,Sanz-Garcia C,Nagy LE.Adiponectin as an anti-fibrotic and anti-inflammatory adipokine in the liver[J].Curr Pathobiol Rep,2015,3(4):243-252.[4]Wang ZV,Scherer PE.Adiponectin,the past two decades[J].J Mol Cell Biol,2016,8(2):93-100.[5]Yamauchi T,Kamon J,Ito Y,et al.Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J].Nature,2003,423(6941):762-769.[6]Hug C,Wang J,Ahmad NS,et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[J].Proc Natl Acad Sci USA,2004,101(28):10308-10313.[7]Kishida K,Funahashi T,Shimomura I.Adiponectin as a routine clinical biomarker[J].Best Pract Res Clin Endocrinol Metab,2014,28(1):119-130.[8]Fang H,Judd RL.Adiponectin Regulation and Function[J].Compr Physiol,2018,8(3):1031-1063.[9]王光亚,苏娜,许金秀,等.2型糖尿病合并代谢综合征患者血浆APN和PAI-1检测的临床意义[J].河北医药,2010(7):75-76.[10]Ohashi K,Parker JL,Ouchi N,et al.Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype[J].J Biol Chem,2010,285(9):6153-6160.[11]Gordon S,Martinez FO.Alternative activation of macrophages:mechanism and functions[J].Immunity,2010,32(5):593-604.[12]Takemura Y,Ouchi N,Shibata R,et al.Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies[J].J Clin Invest,2007,117(2):375-386.[13]Ding X,Saxena NK,Lin S,et al.The roles of leptin and adiponectin:a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology[J].Am J Pathol,2005,166(6):1655-1669.[14]Adachi M,Brenner DA.High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase[J].Hepatology,2008,47(2):677-685.[15]Xu A,Wang Y,Keshaw H,et al.The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[J].J Clin Invest,2003,112(1):91-100.[16]Kamada Y,Tamura S,Kiso S,et al.Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin[J].Gastroenterology,2003,125(6):1796-1807.[17]Kamada Y,Matsumoto H,Tamura S,et al.Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model[J].J Hepatol,2007,47(4):556-564.[18]Shafiei MS,Shetty S,Scherer PE,et al.Adiponectin regulation of stellate cell activation via PPARgamma-dependent and-independent mechanisms[J].Am J Pathol,2011,178(6):2690-2699.[19]Rinella ME.Nonalcoholic fatty liver disease:a systematic review[J].JAMA,2015,313(22):2263-2273.[20]宋新文,申保生,王宏伟.非酒精性脂肪性肝病患者血清脂联素和瘦素水平变化[J].实用肝脏病杂志,2013,16(2):141-143.[21]Musso G,Gambino R,Biroli G,et al.Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis[J].Am J Gastroenterol,2005,100(11):2438-2446.[22]Chernyak OO,Sentsova TB,Vorozhko IV,et al.Genomic,proteomic and metabolomic predictors of nonalcoholic fatty liver disease development in obese patients[J].Part Vopr Pitan,2015,84(4):18-24.[23]Moschen AR,Molnar C,Wolf AM,et al.Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression[J].J Hepatol,2009,51(4):765-777.[24]Oh S,Tanaka K,Tsujimoto T,et al.Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease[J].Metab Syndr Relat Disord,2014,12(5):290-298.[25]Polyzos SA,Toulis KA,Goulis DG,et al.Serum total adiponectin in nonalcoholic fatty liver disease:a systematic review and meta-analysis[J].Metabolism,2011,60(3):313-326.[26]Wong VW,Wong GL,Choi PC,et al.Disease progression of non-alcoholic fatty liver disease:a prospective study with paired liver biopsies at 3 years[J].Gut,2010,59(7):969-974.[27]Zelber-Sagi S,Lotan R,Shlomai A,et al.Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up[J].J Hepatol,2012,56(5):11450-11451.[28]Musso G,Bo S,Cassader M,et al.Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism[J].Am J Clin Nutr,2013(98):895-906.[29]Salman A,Hegazy M,AbdElfadl S.Combined Adiponectin Deficiency and Resistance in Obese Patients:Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis[J].Open Access Maced J Med Sci,2015,3(2):298-302.[30]Nazal L,Riquelme A,Solis N,et al.Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients[J].Obes Surg,2010,20(10):1400-1407.[31]Savvidou S,Hytiroglou P,Orfanou-Koumerkeridou H,et al.Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD[J].J Clin Gastroenterol,2009,43(8):765-772.[32]van der Poorten D,Samer CF,Ramezani-Moghadam M,et al.Hepatic fat loss in advanced nonalcoholic steatohepatitis:are alterations in serum adiponectin the cause[J].Hepatology,2013,57(6):2180-2188.[33]Polyzos SA,Kountouras J,Zavos C.Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis[J].J Clin Gastroenterol,2010,44(3):229-230.[34]Chiang CH,Lai JS,Hung SH,et al.Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers[J].Obesity(Silver Spring),2013,21(2):291-296.[35]Hsu CS,Liu CH,Wang CC,et al.Impact of hepatitis B virus infection on metabolic profiles and modifying factors[J].J Viral Hepat,2012,19(2):e48-e57.[36]Nitzan Kaluski D,Halpern Z,Oren R.Increased circulating adiponectin in males with chronic HCV hepatitis[J].Eur J Intern Med,2015,26(8):635-639.[37]Corbetta S,Redaelli A,Pozzi M,et al.Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection[J].Eur J Clin Invest,2011,41(8):898-905.[38]Hui CK,Zhang HY,Lee NP,et al.Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B[J].J Hepatol,2007,47(2):191-202.[39]Siagris D,Vafiadis G,Michalaki M,et al.Serum adiponectin in chronic hepatitis C and B[J].J Viral Hepat,2007,14(8):577-583.[40]Tsochatzis E,Papatheodoridis GV,Hadziyannis E,et al.Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity[J].Scand J Gastroenterol,2008,43(9):1128-1136.[41]Derbala M,Rizk N,Al-Kaabi S,et al.Adiponectin changes in HCV-Genotype 4:relation to liver histology and response to treatment[J].J Viral Hepat,2009,16(10):689-696.[42]Hsu CS,Liu WL,Chao YC,et al.Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection[J].Hepatol Int,2015,9(2):231-242.[43]Wong VW,Wong GL,Yu J,et al.Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese[J].Am J Gastroenterol,2010,105(1):132-138.[44]Carvalho RF,Atta AM,de Oliveira IS,et al.Adiponectin levels and insulin resistance among patients with chronic hepatitis C[J].Acta Trop,2018(178):258-263.
相似文献/References:
[1]刘 波,罗文静,张 翼,等.血清脂联素水平与轻度认知功能障碍的相关性研究[J].医学信息,2018,31(10):7.[doi:10.3969/j.issn.1006-1959.2018.10.003]
LIU Bo,LUO Wen-jing,ZHANG Yi,et al.Correlation between Serum Adiponectin Level and Mild Cognitive Impairment[J].Medical Information,2018,31(08):7.[doi:10.3969/j.issn.1006-1959.2018.10.003]
[2]赵 静,陈华琴,张 宁,等.血清骨膜蛋白和脂联素联检诊断儿童支气管哮喘价值研究[J].医学信息,2018,31(21):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
ZHAO Jing,CHEN Hua-qin,ZHANG Ning,et al.Diagnostic Value of Serum Periosteal Protein and Adiponectin in Children with Bronchial Asthma[J].Medical Information,2018,31(08):71.[doi:10.3969/j.issn.1006-1959.2018.21.019]
[3]张利敏,游 婕,朱陈华,等.脂联素和D-二聚体在急性主动脉夹层中的诊断价值[J].医学信息,2022,35(14):62.[doi:10.3969/j.issn.1006-1959.2022.14.013]
ZHANG Li-min,YOU Jie,ZHU Chen-hua,et al.Diagnostic Value of Adiponectin and D-dimer in Acute Aortic Dissection[J].Medical Information,2022,35(08):62.[doi:10.3969/j.issn.1006-1959.2022.14.013]
[4]赵方新,张 烜,陆景坤,等.斑马鱼肝脏组织油红O染色方法比较优化[J].医学信息,2022,35(17):27.[doi:10.3969/j.issn.1006-1959.2022.17.006]
ZHAO Fang-xin,ZHANG Xuan,LU Jing-kun,et al.Comparison and Optimization of Oil Red O Staining Methods in Liver Tissue of Zebrafish[J].Medical Information,2022,35(08):27.[doi:10.3969/j.issn.1006-1959.2022.17.006]
[5]彭小飞,张 涵,廖家李,等.脂联素在乳腺癌组织中的表达及其临床意义[J].医学信息,2021,34(06):6.[doi:10.3969/j.issn.1006-1959.2021.06.002]
PENG Xiao-fei,ZHANG Han,LIAO Jia-li,et al.The Expression of Adiponectin in Breast Cancer Tissues and Its Clinical Significance[J].Medical Information,2021,34(08):6.[doi:10.3969/j.issn.1006-1959.2021.06.002]
[6]杨立顺,陈思佳,康建华.miRNA和脂联素在2型糖尿病发病机制中的研究[J].医学信息,2021,34(08):50.[doi:10.3969/j.issn.1006-1959.2021.08.013]
YANG Li-shun,CHEN Si-jia,KANG Jian-hua.Study on miRNA and Adiponectin in the Pathogenesis of Type 2 Diabetes Mellitus[J].Medical Information,2021,34(08):50.[doi:10.3969/j.issn.1006-1959.2021.08.013]
[7]方云生.骨填充网袋椎体成形术治疗骨质疏松性椎体压缩性骨折的效果[J].医学信息,2021,34(14):121.[doi:10.3969/j.issn.1006-1959.2021.14.032]
FANG Yun-sheng.The Effect of Bone Filling Mesh Bag Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures[J].Medical Information,2021,34(08):121.[doi:10.3969/j.issn.1006-1959.2021.14.032]
[8]寇 天,郝振伟,陈 曦.APN、OX-LDL和TBIL水平与冠心病患者发生冠状动脉病变的关系研究[J].医学信息,2023,36(03):84.[doi:10.3969/j.issn.1006-1959.2023.03.017]
KOU Tian,HAO Zhen-wei,CHEN Xi.The Relationship Between APN, OX-LDL, TBIL Levels and Coronary Artery Disease in Patients with Coronary Heart Disease[J].Medical Information,2023,36(08):84.[doi:10.3969/j.issn.1006-1959.2023.03.017]
[9]胡丽平,蔡 华,李情娇,等.代谢相关脂肪性肝病发病机制的研究[J].医学信息,2023,36(23):174.[doi:10.3969/j.issn.1006-1959.2023.23.044]
HU Li-ping,CAI Hua,LI Qing-jiao,et al.Study on the Pathogenesis of Metabolism Associated Fatty Liver Disease[J].Medical Information,2023,36(08):174.[doi:10.3969/j.issn.1006-1959.2023.23.044]